Ketamine

This article is a stub.

Ketamine is not routinely available in New Zealand (oral or IV).

Ketamine is associated with various adverse effects, including: Psychomimetic effects (e.g., hallucinations, memory defects), Cardiovascular stimulation, Gastrointestinal disturbances, Potential for addiction. There is a lack of safety data concerning long-term or repeated treatments.

Resources

Ketamine - FPM 2022.PDF - 316 KB (f)

Ketamine risks and benefits - Niesters 2012.pdf - 972 KB (f)

Ketamine Consensus Guidelines for IV Ketamine - Cohen 2018pdf.pdf - 456 KB (f)